BioNJ released “A Framework for Demonstrating the Value of Medical Innovation,” a white paper authored by Shailja Dixit, M.D., M.S., M.P.H., President & Founder, ApexBio, and Robert Goldberg, Ph.D., Vice President & Founder, Center for Medicine in the Public Interest, that outlines a structure for innovator companies to assess and demonstrate “Differential Value” for a medical innovation prior to bringing it to market.
June 5, 2019
· 3 min read